SAGETTARIUS: a program to reduce the number of tags mapped to multiple transcripts and to plan SAGE sequencing stages by Bianchetti, Laurent et al.
Published online 20 September 2007 Nucleic Acids Research, 2007, Vol. 35, No. 18 e122
doi:10.1093/nar/gkm648
SAGETTARIUS: a program to reduce the number
of tags mapped to multiple transcripts and
to plan SAGE sequencing stages
Laurent Bianchetti
1,*, Yan Wu
1, Eric Guerin
2, Fre ´de ´ric Plewniak
1 and Olivier Poch
3
1Plate-forme Bioinformatique de Strasbourg, Institut de Ge ´ne ´tique et de Biologie Mole ´culaire et Cellulaire
(CNRS/INSERM/ULP) BP 163, 67404 Illkirch Cedex,
2Inserm U682, Strasbourg, Laboratoire de Biochimie -
Biologie Mole ´culaire, CHU Strasbourg - Ho ˆpital de Hautepierre and
3Laboratoire de Bioinformatique et de
Ge ´nomique Inte ´gratives, Institut de Ge ´ne ´tique et de Biologie Mole ´culaire et Cellulaire (CNRS/INSERM/ULP)
BP 163, 67404 Illkirch Cedex, France
Received May 18, 2007; Revised July 20, 2007; Accepted August 6, 2007
ABSTRACT
SAGE (Serial Analysis of Gene Expression) experi-
ments generate short nucleotide sequences called
‘tags’ which are assumed to map unambiguously
to their original transcripts (1 tag to 1 transcript
mapping). Nevertheless, many tags are generated
that do not map to any transcript or map to multiple
transcripts. Current bioinformatics resources, such
as SAGEmap and TAGmapper, have focused on
reducing the number of unmapped tags. Here, we
describe SAGETTARIUS, a new high-throughput
program that performs successive precise Nla3
and Sau3A tag to transcript mapping, based on
specifically designed Virtual Tag (VT) libraries. First,
SAGETTARIUS decreases the number of tags
mapped to multiple transcripts. Among the various
mapping resources compared, SAGETTARIUS per-
formed the best in this respect by decreasing up
to 11% the number of multiply mapped tags.
Second, SAGETTARIUS allows the establishment
of a guideline for SAGE experiment sequencing
efforts through efficient mapping of the CRT
(Cytoplasmic Ribosomal protein Transcripts)-
specific tags. Using all publicly available human
and mouse Nla3 SAGE experiments, we show that
sequencing 100000 tags is sufficient to map almost
all CRT-specific tags and that four sequencing
stages can be identified when carrying out a
human or mouse SAGE project. SAGETTARIUS is
web interfaced and freely accessible to academic
users.
INTRODUCTION
Genome-wide gene expression proﬁling is now possible,
thanks to the development of complementary high-
throughput techniques such as Expressed Sequence Tag
(EST) (1), diﬀerential display (2), cDNA microarray (3),
genome tiling array (4), SAGE (5) and the associated
LongSAGE (6) adaptation. cDNA microarrays and
genome tiling arrays are based on cDNA target hybridiza-
tions with complementary nucleic acid probes immo-
bilized on a surface. The nucleotide sequence of the probes
determines which transcripts can be hybridized, and
thus which gene expressions can be measured. In contrast
to cDNA hybridization strategies, EST, diﬀerential
display, SAGE and LongSAGE all rely on the cloning
and sequencing of cDNA. EST are randomly selected
cDNA clones and they have applications in the character-
ization of gene products and new gene discovery (1),
they may although not be eﬀective enough to detect
low-abundance transcripts (7). Diﬀerential display is a
comparative approach which focuses on identifying
diﬀerentially expressed genes between two cell samples.
Finally, SAGE and LongSAGE can provide a measure of
all individual gene expressions, including novel genes.
Both methods require strong sequencing eﬀorts, but the
wealth of gene expression information obtained justiﬁes
the investment (8). SAGE has been successfully used to
characterize the transcriptomes of yeast (9) and higher
eukaryote cell types, both in healthy (10,11) and patho-
logical situations, especially cancer (12,13). Moreover,
LongSAGE should signiﬁcantly improve genome annota-
tion (14,15). Brieﬂy, a SAGE experiment involves
the isolation and reverse transcription of all 30 poly-
adenylated mRNA expressed in a cell and the cloning,
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of 10nt called Experimental Tags (ET). The ET are
derived from a particular position of the mRNA deter-
mined by a restriction enzyme site (anchoring enzyme) (5).
The LongSAGE adaptation of SAGE generates longer
ET sequences of 17nt. The observed ET sequence copy
frequencies provide the relative expression levels of the
transcripts in the cells. A tag is deﬁned by the 10 or 17nt
sequence which is directly downstream of the most
30 anchoring enzyme restriction site on a 30 poly-
adenylated mRNA. Nla3, which recognizes the CATG
motif, is the most widely used anchoring enzyme, but
Sau3A, which cleaves DNA at GATC sites, has also been
used in SAGE protocols. Once sequenced and counted,
the thousands of ET generated by SAGE or LongSAGE
experiments must be mapped to their original transcripts
in order to identify the genes expressed in the cells.
ET to gene mapping is a bioinformatics task which
requires the pre-construction of a specialized database of
Virtual Tags (VT). VT are tags which are extracted from
transcript sequences recorded in nucleic acid databases,
and the VT sequences are associated with the transcripts
or genes from which they derive. During the mapping
process, ET are compared to VT. When an ET matches a
VT, the ET is mapped to the transcript or gene with which
the VT is associated, and as a result the identity of the
gene which is expressed in the cell is determined. SAGE
postulates that ET sequences are random and long enough
to be mapped without ambiguity to their original gene.
Theoretically, 10nt can generate 4
10 (1048576) diﬀerent
sequences. For human and mouse genomes, this repertoire
of short sequences is largely above the estimated number
of 30000–40000 diﬀerent protein coding genes (16,17).
Moreover, even the repertoire of human and mouse
transcripts which has been estimated at 92000 distinct
mRNA (18) is less than the 4
10 possibilities of SAGE tag
sequences. Consequently, the mapping process is expected
to map without ambiguity any ET to a single gene.
However, in practice, the mapping process has come up
against two major obstacles, namely unmapped and
multiply mapped ET. Indeed, many ET do not map to
any gene (19–21). Unmapped ET may account for
the expression of novel transcripts or they could be the
result of an accumulation of sequencing errors (22). Most
bioinformatics developments have focused on decreasing
the rate of unmapped ET and recently, the TAGmapper
tool (21) has been shown to signiﬁcantly reduce the rate
of unmapped ET by means of a 7.1 million specialized
VT database. A non-negligible rate of ET has also been
reported to map to multiple genes (23,24). Indeed, it has
been estimated that a third of human ET are shared by
diﬀerent genes (22), due to the fact that 10nt long ET
sequences might be too short to be speciﬁc to a single
gene. Therefore, the LongSAGE technique which gener-
ates 17nt long ET may prove to be more useful for
resolving multiply mapped ET ambiguities (22).
The reasons why ET may map to multiple genes are
debatable. First, ET are sequenced only once and are thus
susceptible to sequencing errors. VT are also susceptible
to sequencing errors because they derive from transcript
records which are of variable primary sequence quality.
Due to these sequence errors, false positive matches
between ET and VT may occur. Second, transcripts may
contain Interspersed Repetitive Elements (IRE) (25,26)
which introduce common subsequences. SAGE tags
extracted from IRE sequences are likely to lead to
multiply mapped ET. Third, multiple gene mapping
may also be a consequence of the VT database construc-
tion procedure itself. For example, SAGEmap and
SAGE Genie mapping resources (27) both propose a VT
database which contains internal tags, i.e. VT extracted
from 50 anchoring enzyme sites on an mRNA sequence
and TAGmapper also integrates VT extracted from
transcripts lacking a 30 poly-adenylated boundary.
These approaches may lead to multiple gene mapping
by generating additional matches with VT sequences.
Finally, the low complexity of some tag sequences may
also lead to multiple gene mapping. For example, the
AAAAAAAAAA VT is shared by many diﬀerent
transcript sequences whose most 30 anchoring enzyme
site occurs just before the 30 poly-adenylated boundary.
As a consequence, an AAAAAAAAAA ET will map
every transcript associated with an AAAAAAAAAA VT.
The use of Sau3A as an alternative anchoring enzyme
to carry out a SAGE experiment may help to resolve tag
to transcript mapping ambiguities encountered when
using Nla3. As an example, the human Ribosomal
Protein 4 (RPL4) transcript (NM_000968) is associated
with an Nla3 AAAAAAAAAA tag, whereas its Sau3A
tag is CATCGCAGAG. Although Sau3A SAGE experi-
ments are less frequent, the maintenance of an Sau3A
mapping resource should be a useful tool for some tag
to multiple transcript associations.
Human and mouse SAGE experiments, which represent
86% of all publicly available SAGE libraries, have
generated several millions of ET sequences (22), and as
a consequence automatic procedures are now required
to map ET to their original genes. Here, we present a new
mapping strategy and a new VT database both integrated
in a web-interfaced tool, SAGETTARIUS, speciﬁcally
designed to address the problem of ET to multiple gene
mapping. In fact, SAGETTARIUS performs ET to
transcript rather than gene mapping. SAGETTARIUS
distinguishes three groups of VT to transcript associa-
tions, according to mRNA primary sequence quality:
individually cloned and veriﬁed cDNA (28); High-
Throughput cDNA (HTC) (29) which are full-length
mRNA, but may be of draft quality (30,31), and
Expressed Sequence Tags (EST) which are fragmentary
sequences containing a 1% base error rate and thus a
VT extracted from an EST has a 10% chance of being
false (23). SAGETTARIUS implements a progressive
and reductive mapping procedure, during which ET
are compared to the three groups of VT to transcript
associations.
Furthermore, biologists who plan a SAGE project
must decide how many ET to sequence. The number
will be a compromise between the gene expression infor-
mation beneﬁt required and the associated sequencing
eﬀort. Indeed, the number of ET required to deﬁne a
cell transcriptome depends on the conﬁdence level desired
for detecting low-abundance mRNA molecules (9).
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contains about 300000–570000mRNA molecules (32)
which means that at least 300000 ET should be sequenced
in order to cover the smallest transcriptome. Publicly
deposited SAGE collections of ET range from a few
thousand to more than 300000 sequenced ET. Currently,
most SAGE experiments collect from 50000 to 100000 ET
sequences (22), but no guidelines exist for the eﬃcient
planning of ET sequencing stages. The mapping of ET
derived from a reference family of ubiquitously expressed
mRNA, ideally containing high-, medium- and low-
abundance transcripts (33) would provide a practical
framework to plan a SAGE project with successive
sequencing stages. In this study, we have investigated
whether the CRT can be used as a reference family of
mRNA to propose a guideline for SAGE sequencing
stages.
MATERIALS AND METHODS
Publicly available SAGE experiments
We downloaded all the publicly available Homo sapiens
and Mus musculus Nla3 SAGE experiments from the
Gene Expression Omnibus server (34,35). Thus, 371
human and 123 mouse SAGE experiments were collected.
These SAGE experiments originate from various cell
types, developmental stages, physiological conditions
and pathological situations. The smallest (GSM718,
SAGE_HMEC-B41) and largest (GSM14799, SAGE_
Brain_fetal_normal_B_S1) human Nla3 SAGE experi-
ments contain respectively, 1430 and 308589 sequenced
ET, whereas the smallest (GSM5050, P10 cerebellum)
and largest (GSM75582, SAGE_hypothalamus_
adrenalectomized) mouse Nla3 SAGE experiments
contain respectively, 464 and 194345 sequenced ET.
The eﬃciency of the SAGETTARIUS ET to transcript
mapping procedure has been evaluated on the GSM14740
experiment (SAGE_Brain_ependymoma_B_R1023 with
122690 sequenced ET and 40027 unique ET sequences).
A sample of 8 human Nla3 SAGE experiments has been
used to evaluate the number of IRE-derived ET mapped
to multiple transcripts: GSM23394 (THP-1, cultured
THP-1 cells; 2147 unique ET), GSM764 (SAGE_normal_-
prostate; 6719 unique ET), GSM14804 (SAGE_
Lung_normal_CL_L15; 9078 unique ET), GSM14805
(SAGE_Lung_normal_CL_L16; 11894 unique ET),
GSM762 (SAGE_normal_lung; 24962 unique ET),
GSM14740 (SAGE_Brain_ependymoma_B_R1023;
40027 unique ET), GSM41378 (SAGE_Embryonic_
stem_cell_H9_normal p38_CL_SHES1; 37097 unique
ET) and GSM14799 (SAGE_Brain_fetal_normal_B_S1;
80125 unique ET).
SAGEmap resources of H.sapiens Nla3VT
to Unigenecluster associations
We downloaded from the SAGEmap (NCBI) bioinfor-
matics mapping server (ftp://ftp.ncbi.nlm.nih.gov/pub/
sage/map/Hs/Nla3) both ‘full’ and ‘reliable’ resources
of human Nla3 VT to Unigene cluster associations,
built from Genbank version 151 and H. sapiens Unigene
release 187. These resources propose VT associated
with Unigene clusters of transcripts according to the
SAGEmap procedure (23). Brieﬂy, the ‘full’ resource
contains signiﬁcantly more VT to Unigene cluster
associations than the ‘reliable’ one, although the ‘reliable’
associations are more robust.
Computational servers, operating systems andsource code
A Sun Solaris 9 server with 4  ultra-sparc-3 64 bits
processors, 800MHz and 16GB of RAM hosts the
SAGETTARIUS database of VT to transcript associa-
tions. The database information is currently stored in
a Relational Sybase DBMS (Database Management
System). Updates of the SAGETTARIUS database are
performed on a 6 4 Sun AMD Opteron processors
(2.6GHz) using the Linux Operating System. The
SAGETTARIUS database is queried using Perl 5.6.1
scripts integrating the DBI (Database Interface Module).
The SAGETTARIUS web interface has been developed
in PHP and Perl cgi (common gateway interface) scripts
run on a Sun Enterprise 450 (Solaris 9) server with
four processors, 1GB of shared memory and the Unix
operating system.
Construction ofthe VTto transcript association database
VT to transcript associations stored in the
SAGETTARIUS database all originate from Genbank
(30) (release 151) transcript sequences, except for the VT
to CRT associations which originate from the transcript
sequences of the RefSeq-RNA database (36). Locally
updated copies of Genbank and RefSeq-RNA are
maintained on our bioinformatics platform and are
both indexed with SRS 7.1.3.1 (Sequence Retrieval
Software, Lion Bioscience). The construction of the
SAGETTARIUS database of VT to transcript associa-
tions relies on a three-step process (Figure 1).
(i) The selection and sorting step exhaustively identiﬁes
in Genbank and RefSeq-RNA, the human and mouse
30 poly-adenylated (at least six adenines) transcripts and
classiﬁes the transcripts according to four groups: CRT,
veriﬁed cDNA, HTC and EST. EST sequences that are
50 poly-thymidylated instead of being 30 poly-adenylated
are reversed and complemented. We have also obtained
from RefSeq-RNA the complete catalog of human and
mouse full-length 30 poly-adenylated CRT and their
annotated splicing variants. The Ribosomal Protein
Gene (RPG) database (37) provides the complete list of
the 80 human and 79 mouse cytoplasmic ribosomal
protein coding genes. Using gene name-based queries in
the RefSeq-RNA database, we obtained the CRT
sequence records. When a CRT sequence record contained
a3 0 poly-adenylated boundary and anchoring enzyme
sites, the most 30 VT was extracted according to the SAGE
tag deﬁnition. When a CRT sequence record did not
contain a 30 poly-adenylated boundary, the VT could not
be extracted. Therefore, a blastn search was performed
in the HTC-division of Genbank to ﬁnd a redundant
sequence record displaying an additional 30 poly-
adenylated boundary. The best scoring redundant
HTC (identity percent >98 and identity number >400)
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lacked the 30 poly-adenylated boundary.
(ii) Next, the IRE delineation step compares the human
and mouse 30 poly-adenylated transcript sequences to the
Genetic Information Research Institute (GIRI) collections
of IRE sequences (38) using RepeatMasker V3.1.3
(Smit,A., unpublished data) and Crossmatch (Green,P.,
unpublished data) and identiﬁes IRE sequences integrated
into transcripts and VT derived from IRE sequences.
(iii) Finally in the VT extraction step, VT of both 10 and
17nt lengths are extracted from transcript sequences
to produce VT to transcript associations. Sequence
redundancy is especially frequent among HTC and EST
sequences and leads to the generation of equivalent VT
to transcript associations, i.e. associations displaying
the same VT linked to the same transcript description.
For HTC sequences, all but one of the equivalent associa-
tions are eliminated. SAGETTARIUS uses Unigene
cluster titles and EST accession numbers recorded in
Unigene. Thus, all EST gathered in the same Unigene
cluster and generating the same VT are eliminated
except for one representative sequence. However,
the accession numbers of the eliminated EST are
stored in the SAGETTARIUS database for use in
downstream sequence analyses. Finally, VT to transcript
associations are stored in 32 specialized libraries
(see Supplementary Data at http://bips.u-strasbg.fr/
Sage_docs/Supp_Material.html), according to organism
(human, mouse), anchoring enzyme (Nla3, Sau3A),
tag length (10 or 17nt) and transcript primary sequence
group (CRT, cDNA, HTC, EST).
Calculation of individualCRT detection probability
for10000,50000 and100000 sequenced ET
Among all the human and mouse Nla3 SAGE experiments
available, we have collected the SAGE experiments
with 10000, 50000 and 100000 sequenced ET ( 10%).
For human, the probabilities of CRT detections were
calculated on the available 9, 22 and 8 experiments
with 10000, 50000 and 100000 sequenced ET ( 10%),
respectively. For mouse, the probabilities of CRT
detections were calculated on the available 5, 13 and
2 experiments with 10000, 50000 and 100000 sequenced
ET ( 10%), respectively. For each collected experiment,
we have determined whether the 80 human or 79 mouse
CRT have been individually detected. The probability of
detecting a CRT at 10000, 50000 or 100000 sequenced
ET ( 10%) is deﬁned as the number of times the CRT
has been detected divided by the number of SAGE
experiments.
Genbank
3′ poly-A 
CRT sequences
VT_to_CRT_associations 
3′ poly-A
cDNA sequences
3′ poly-A
HTC sequences
3′ poly-A
or 5′ poly-T EST
sequences
VT_to_cDNA_associations 
VT_to_HTC_associations
equivalent associations
removed 
       
genomic DNA
full-length mRNA,
fragments, EST, ... 
(transcripts)
1) Selection and sorting: exhaustive retrieval of human and mouse 3' poly-adenylated
transcripts (6 adenines at least), sorting of CRT, verified cDNA, HTC and EST.
3) VT extraction: extraction of  Nla3 and Sau3A  most 3' VT from the 3' poly
adenylated transcript sequences
-
2) IRE delineation: comparison of 3' poly-adenylated 
transcript
sequence
redundance
VT_to_EST_associations
equivalent associations
removed 
RefSeq
RNA
Figure 1. Generation of SAGETTARIUS database information. The ﬁnal results of the procedure are VT to transcript associations.
Bold: procedure steps.
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SAGETTARIUS ET to transcript mapping is a progres-
sive and reductive process. Unique ET sequences
generated by a SAGE experiment are progressively
compared to the VT sequences stored in the libraries
of VT_to_CRT_associations, VT_to_cDNA_associations,
VT_to_HTC_associations and VT_to_EST_associations,
according to a four-step process (Figure 2). The process is
reductive because unique ET sequences that match VT
sequences are removed from the ET pool of the SAGE
experiment. At the beginning of the process, unique ET
sequences are compared to the VT sequences of the
VT_to_CRT_associations library (ﬁrst step). Unique ET
sequences which obtain a match in this library are
removed from the pool of ET. Then, the remaining
unique ET sequences are compared to the VT sequences of
the VT_to_cDNA_associations library (second step).
Unique ET sequences which match the VT of this library
are removed from the ET pool. Similarly, comparisons of
the remaining unique ET sequences and VT sequences
are carried out using the VT_to_HTC_associations and
VT_to_EST_associations, successively. At the end of the
process, unique ET sequences which cannot be matched to
any VT sequence in the four libraries remain unmapped.
Web interface
SAGETTARIUS is hosted by the Bioinformatics
Platform of Strasbourg (BIPS) and available through a
user-friendly web interface at http://bips.u-strasbg.fr/
Sage_docs/Sagettarius.php. SAGETTARIUS is interfaced
using three main windows. In the submission window, the
user provides SAGE experiment parameters (organism,
anchoring enzyme, SAGE or LongSAGE protocol) and
uploads a list of unique ET sequences. An e-mail address
is not required to obtain the mapping results. ET to
transcript mapping is displayed in a second window.
The assessment of detected CRT is displayed in a third
window. Results are stored for 1 month after generation
and conﬁdentiality is assured using a user-speciﬁc access
code (job-ID).
RESULTS
VTto CRT associations
The ribosome, which acts as a catalyst for protein
synthesis, is universal and essential for all organisms (39)
and the expression of genes encoding cytoplasmic
ribosomal proteins is expected to be ubiquitous in every
cell. The ribosomal proteins are coded by 80 genes in
human and 79 in mouse. We have constructed curated
libraries of VT to CRT associations for both organisms.
Most 30 poly-adenylated mRNA coding for human
ribosomal proteins are (82%) available in the RefSeq-
RNA database. The remaining 18% are present in the
HTC division of Genbank, although the primary
sequences may be of lower quality. For the mouse
organism, the transcripts coding the 79 cytoplasmic
ribosomal proteins are all available in the RefSeq-RNA
database, but only 28% of them display the mandatory
30 poly-adenylated boundary required to derive VT. We
therefore complemented the RefSeq-RNA mouse
CRT lacking 30 poly-adenylated boundaries by redundant
30 HTC sequences showing a 30 poly-adenylation. For
Nla3 and Sau3A anchoring enzymes, we identiﬁed the
speciﬁcities of CRT and their associated VT (Table 1) such
as CRT displaying AAAAAAAAAA VT, Nla3 and/or
Sau3A undetectable CRT lacking an anchoring enzyme
site, distinguishable versus indistinguishable splicing
transcript variants and VT derived from IRE subse-
quences integrated into CRT. Overall, for both human
and mouse organisms, Nla3 and Sau3A SAGE protocols
respectively detect 76 and 74 CRT which are the products
of diﬀerent ribosomal genes. The human L4 and L13 CRT
are associated with the AAAAAAAAAA VT and there-
fore their expressions are not measurable. Interestingly,
for both organisms, the S21 CRT does not contain any
Nla3 or Sau3A restriction site, making the expression of
the transcript completely undetectable by the current
SAGE experimental protocols. Nla3 detects slightly more
CRT than Sau3A, since two human CRT are undetectable
by Nla3, whereas six are undetectable by Sau3A. For the
mouse organism, 3 CRT cannot be detected by Nla3
and 5 by Sau3A. The transcript splicing variants 1 and
2 coding for S29 protein isoforms display diﬀerent VT and
their expression can thus be distinguished. However,
most CRT splicing variants cannot be distinguished by
SAGE because they have identical VT. Finally, the human
L32 CRT is the only sequence found to contain an IRE
which overlaps the most 30 VT. This VT is identical to
the ERO1-like transcript (AF081886) VT. The human and
VT_to_CRT_associations
VT_to_HTC_associations
Unmapped ET
ET pool
ET pool
ET pool
ET pool 
VT_to_EST_associations
ET
ET
ET
ET
Reduction
Reduction
Reduction 
Reduction
ET mapped to CRT
ET mapped to cDNA
ET mapped to HTC
ET mapped to EST
VT_to_cDNA_associations
ET to VT
sequence
comparisons
ET to VT
sequence
comparisons
ET to VT
sequence
comparisons
ET to VT
sequence
comparisons
Figure 2. SAGETTARIUS progressive and reductive ET to transcript
mapping process.
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be viewed on the web at http://bips.u-strasbg.fr/Sage_bin/
RiboTable.cgi?Hs and Mm, respectively.
VTto cDNA, HTC and ESTassociations
We have exhaustively determined how many VT to
transcript associations can be generated from the tran-
script sequences recorded in Genbank (Table 2). The
SAGETTARIUS automatic procedure which generates
VT to transcript associations counts the total number of
human and mouse 30 poly-adenylated cDNA, HTC and
EST sequences recorded in Genbank. In Genbank release
156, the total number of transcript sequence records
reaches 6.9 and 4.2 million for human and mouse,
respectively. Most of these transcripts are EST (6.7 million
for human and 4 million for mouse). Individually cloned
and veriﬁed cDNA are the least represented group of
transcripts. They account for 31331 human and 15153
mouse sequences. Unexpectedly, more than twice as many
HTC have been sequenced for mouse (169332) than for
human (75275). The 30 poly-adenylation of a transcript
sequence is mandatory to derive a robust VT to transcript
association, and therefore we have determined how many
Genbank transcripts contain a 30 poly-adenylation of at
least six adenines. A total of 6206 sequences out of 31331
human veriﬁed cDNA show a 30 poly-adenylated bound-
ary (2955 out of 15153 for mouse). 30 poly-adenylated
HTC represent 18099 human and 15703 mouse sequence
records. Furthermore, 30 poly-adenylated HTC are a
subset of all HTC. Finally, 30 poly-adenylated EST
(693858 human and 196048 mouse sequences) also
represent a subset of the total EST sequence records.
Overall, 718161 human and 214706 mouse 30 poly-
adenylated transcript records were used to derive VT to
transcript associations. Nla3 and Sau3A VT to transcript
associations have been exhaustively derived from the
Table 1. Characteristics of Nla3 and Sau3 VT sequences associated with human and mouse CRT. t.v.: splicing Transcript Variant. Asterisk symbol:
no CRT presents this characteristic.
Homo sapiens Mus musculus
Total number of genes
encoding ribosomal proteins
80 79
Anchoring enzyme Nla3 Sau3A Nla3 Sau3A
Detectable CRT
(splicing variants excluded)
76 74 76 74
AAAAAAAAAA tag L4, L13     
Undetectable CRT S21, L7A S10, S12, S21, S25
L35A, L36
S21, L6, L35A S21, S25, L31
L37, L37A
Distinguishable CRT
splicing variants
S29t.v. 1 & 2 S24t.v. 1 & 2
S29t.v. 1 & 2
  
Indistinguishable CRT
splicing variants
(Variants 1 and 2)
(Variants 1, 2 and 3)
S15A, S24, L3, L6,
L8, L9, L14, L17,
L34, L38,UBA52,
L41, P0
L32
S15A, L3, L6, L8,
L9, L14, L17, L34,
L38, UBA52, L41,
P0, SA
S14, L32
  
VT derives from an IRE
integrated in the CRT
  L32 displays the same VT
as the ERO1-like mRNA
(F081886)
  
Table 2. VT to cDNA, HTC and EST associations in the
SAGETTARIUS database. This assessment has been established on
the database of VT to transcript associations built from Genbank
release 156. H.s.: Homo sapiens, M.m.: Mus musculus. tr. seq.:
transcript sequence. n.d.: not determined.
cDNA HTC EST
H.s. M.m. H.s. M.m. H.s. M.m.
Genbank tr.
seq. records
31331 15153 75275 169332 6771069 4059938
Genbank 30 poly-A
tr. seq. records
6206 2955 18099 15703 693858 196048
VT to tr. seq.
associations (Nla3)
6155 2936 13537 12541 135793 60535
VT to tr. seq.
associations (Sau3A)
6025 2898 13099 12190 105297 43985
tr. seq. without
Nla3 site
51 19 101 86 n.d. n.d.
tr. seq. without
Sau3A site
181 57 485 325 n.d. n.d
tr. seq. without
Nla3/Sau3 site
4 1 15 10 n.d. n.d
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and EST, equivalent VT to transcript associations were
removed. We have observed that Nla3 provides slightly
more VT to transcript associations than Sau3A, which
means practically that Nla3 can map more ET than
Sau3A. Total 6155 and 2936 Nla3 VT to transcript
associations were derived from individually cloned and
veriﬁed cDNA for human and mouse, respectively.
30 poly-adenylated HTC generated 13537 human and
12541 mouse Nla3 non-equivalent VT to transcript
associations. In addition, 135793 human and 60535
mouse Nla3 non-equivalent VT to transcript associations
were created from 30 poly-adenylated EST. The
SAGETTARIUS database (Genbank release 156)
includes a total of 155471 human Nla3 VT to transcript
associations and 76012 for mouse. These VT to transcript
associations exceed the estimated repertoire of genes and
transcripts coded by the human and mouse genomes.
Interestingly, we noticed that some 30 poly-adenylated
transcripts do not generate any VT to transcript associa-
tions due to a lack of anchoring enzyme sites on their
sequences. Total 41 human-veriﬁed cDNA lack the Nla3
site (16 for mouse) and four times as many transcripts
were found to lack the Sau3A site. Finally, four human
transcripts, supported by veriﬁed cDNA records are
undetectable by both Nla3 and Sau3A anchoring enzymes:
Rad51C truncated protein (AF029670); apoptosis-related
protein PNAS-1 (AF229831); PNAS-117 (AF275813) and
as previously mentioned the ribosomal protein S21
(NM_001024) encoding mRNA. For mouse, only the
S21 mRNA cannot be detected. An exhaustive list of
transcripts which escape the expression measure by Nla3,
Sau3A or both enzyme SAGE protocols is accessible on
the SAGETTARIUS web site. This list will be updated
every 2 months in conjunction with Genbank releases.
Unique VTsequences associated withasingle
versus multiple transcripts
In the SAGETTARIUS database of VT to transcript
associations, we have determined the number of unique
VT sequences which are associated with a single versus
multiple transcripts (Table 3). Almost twice as many
unique VT sequences are available for human (120234)
than for mouse (65497). For human, 84% of unique VT
sequences are associated with a single transcript, and 91%
for mouse. Thus, unique VT sequences associated with
multiple transcripts account for 16 and 9% VT respec-
tively for the two organisms. We have also investigated
whether the lengthening of VT from 10 to 17nt performed
by the LongSAGE technique can help to reduce the
percentage of unique VT sequences associated with
multiple transcripts. We observed that the number of
unique VT sequences increases by a factor of 1.2 when
long VT are extracted from 30 poly-adenylated transcripts
and that the percentage of unique VT sequences asso-
ciated with multiple transcripts decreases to 6 and 4% for
human and mouse, respectively. Thus, the LongSAGE
protocol signiﬁcantly decreases the percentage of unique
VT sequences associated with multiple transcripts. This
is consistent with the fact that 17nt long tags are more
speciﬁc than 10nt. However, 8327 and 3019 unique VT
sequences remain associated with multiple transcripts
for human and mouse, respectively.
SAGE sequencing stages basedon the detection
ofCRT-specific tags
We have estimated how many ET should be sequenced
when planning a human or mouse SAGE project in order
to map the 80 human or 79 mouse CRT-speciﬁc tags. It is
noteworthy that the expression of the complete repertoire
of human and mouse CRT cannot be detected by Nla3
or Sau3A SAGE protocols, since several CRT sequences
lack the anchoring enzyme sites or are associated with
AAAAAAAAAA tags. However, the expression of 76
CRT should be detected by Nla3 (74 CRT for Sau3A)
for both organisms. We downloaded the ET collections of
all publicly available H. sapiens and M. musculus Nla3
SAGE experiments from the Gene Expression Omnibus
server, with the number of sequenced ET ranging
from 1430 to 308589 and 464 to 194345, respectively.
The unique ET sequences collected in all experiments
were automatically mapped to their transcripts by
SAGETTARIUS and the detected CRT-speciﬁc tags
were counted. We observed that the number of detected
CRT-speciﬁc tags increases with the number of sequenced
ET in both organisms (Figure 3). Here, we propose to use
the detection of CRT-speciﬁc tags to deﬁne four major
sequencing stages when planning a human or mouse
SAGE experiment. The initial sequencing of 10000 ET
corresponds to a rapid increase in CRT-speciﬁc tag
detection (stage 1). Total 10000 ET allows the detection
of 63 CRT with a probability greater than 0.66 (Table 4)
in human and mouse. The sequencing of 40000 additional
ET (stage 2) substantially increases the number of detected
CRT-speciﬁc tags which reaches 65 in human and 69
in mouse with a probability greater than 0.66. The
sequencing of a further 50000 ET (stage 3) allows the
detection of 69 CRT in human and 70 in mouse. Finally,
the sequencing of more than 100000 ET corresponds to a
plateau in CRT-speciﬁc tag detection (stage 4). We have
analyzed the probabilities of individual CRT-speciﬁc tag
detection in Nla3 human and mouse SAGE experiments
with 10000  10%, 50000  10% and 10000  10%
sequenced ET (Table 4 and also Supplementary Data at
Table 3. Unique VT sequences associated with a single vs multiple
transcripts in the SAGETTARIUS database (Nla3). H.s: Homo sapiens,
M.m: Mus musculus. SAGE: 10nt VT, LongSAGE: 17nt VT. tr.:
transcript
VT to transcript (cDNA, HTC, EST)
associations
H.s. M.m.
SAGE LongSAGE SAGE LongSAGE
unique VT seq. 120234 149853 65497 72800
unique VT seq. associated
to a single tr.
101117 141526 59440 69781
unique VT seq. associated
to multiple tr.
19117 8327 6057 3019
PAGE 7 OF 12 Nucleic Acids Research, 2007, Vol. 35,No. 18 e122http://bips.u-strasbg.fr/Sage_docs/Supp_Material.html for
details). We have derived three classes of CRT detection
Probabilities (P): high (P>0.66), medium (0.66 
P>0.33) and low (P 0.33). In human, a set of 63 CRT
display a high detection probability at stages 1, 2 and 3 of
ET sequencing. Outside this set, the more ET are
sequenced, the greater is the probability to detect most
of the remaining CRT (SA, S4Y, S23, S24, L14, L22, L32,
L34, L23A and UBA52). The human L10, L28 and L37
CRT invariably remain in the low probability detection
class at stages 1, 2 and 3 of ET sequencing. In mouse, a set
of 62 CRT display a high detection probability at stages 1,
2 and 3 of ET sequencing. Moreover, 53 CRT of these
CRT have human orthologs in the set of the 63 human
CRT which display a high detection probability at stages
1, 2 and 3 of ET sequencing. The more ET are sequenced,
the greater is the probability to detect most of the
remaining mouse CRT (S15A, S8, S16, S17, L7, L14,
L27A, L29 and L22). The mouse S25, L28, and L36 CRT
invariably remain in the low probability detection class at
stages 1, 2 and 3 of ET sequencing. Moreover, the mouse
L10 CRT was not detected in any SAGE experiment.
A number of discrepancies are observed, e.g. the human
SA CRT requires at least the sequencing of 100000 ET to
be part of the medium detection probability class, whereas
its mouse ortholog already belongs to the high detection
probability class when 10000 ET are sequenced. In addi-
tion, the human L37 CRT invariably belongs to the low
detection probability class regardless of the sequencing
stage, whereas the mouse ortholog is invariably part of the
high detection probability class. Unexpectedly, the mouse
L26 CRT is more likely to be detected when less ET are
sequenced. Some of these discrepancies might be due
to the SAGE experiment sampling.
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Figure 3. Progressive detection of CRT-speciﬁc tags in (a) 371 human
Nla3 SAGE experiments with the number of sequenced ET ranging
from 1430 to 308589 and (b) 123 mouse Nla3 SAGE experiments with
the number of sequenced ET ranging from 464 to 194345. In both
human and mouse, SAGE experiments can be divided into four major
sequencing stages (- -) based on the detection of CRT-speciﬁc tags.
Table 4. Probabilities (P) of individual CRT-speciﬁc tag detections correlated with the number of sequenced ET in human and mouse SAGE
experiments. Group A contains 63 human CRT, namely S2, S3, S3A, S4X, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S15A, S16, S17, S18, S19,
S20, S25, S26, S27, S27A, S28, S29, S30, L3, L5, L6, L7, L8, L9, L10A, L11, L12, L13A, L15, L17, L18, L18A, L19, L21, L23, L24, L26, L27,
L27A, L29, L30, L31, L35, L35A, L36, L36A, L37A, L38, L39, L41, P0, P1 and P2. Group B contains 62 mouse CRT, namely SA, S2, S3, S3A, S4,
S5, S6, S7, S9, S10, S11, S12, S13, S14, S15, S18, S19, S20, S23, S24, S26, S27, S27A, S28, S29, FBR-MuSV, L3, L4, L5, L7A, L8, L9, L10A, L11,
L12, L13, L13A, L15, L17, L18, L18A, L19, L21, L23, L23A, L24, L27, L30, L31, L32, L34, L35, L36A, L37, L37A, L38, L39, UBA52, L41, P0, P1
and P2. Bold: invariably low detectable CRT
Sequenced
ET
Homo sapiens Mus musculus
High
P>0.66
Medium
0.66>P>0.33
Low
P<0.33
High
P>0.66
Medium
0.66>P>0.33
Low
P<0.33
10000
 10%
Group A S24, L14 SA, S4Y, S23, L10, L22, L23A,
L28, L32, L34, L37, UBA52
Group B,
L26
S8, S16, S17,
L7, L14, L27A, L29
S15A, S25,
L10, L22,
L28, L36
50000
 10%
Group A,
S24, L14
S4Y, S23,
L22, L23A
SA, L10, L28, L32, L34, L37,
UBA52
Group B,
S8, S16, S17, L7, L14,
L27A, L29
S15A, L26, S25, L10,
L22, L28,
L36
100,000
 10%
Group A, S23, S24,
L14, L22,
L23A,
UBA52
SA, S4Y,
L32, L34
L10, L28, L37 Group B,
S8, S16, S17,
L7, L14, L22,
L27A, L29
S15A S25, L10,
L26, L28,
L36
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SAGETTARIUS andother tools
We mapped the 40027 unique ET sequences generated by
the GSM14740 (SAGE_Brain_ependymoma_B_R1023)
SAGE experiment with SAGETTARIUS, TAGmapper,
SAGEmap-reliable and SAGEmap-full. SAGETTARIUS
maps ET sequences to transcripts, whereas the other tools
(TAGmapper, SAGEmap-reliable and SAGEmap-full)
map ET sequences to Unigene clusters. For each tool
output, the number of ET sequences mapped to a single,
multiple and no transcript or Unigene clusters respectively
were counted (Figure 4). Important diﬀerences were
observed between the outputs of the 4 ET mapping
resources. SAGETTARIUS performed the best for the
reduction of ETs to multiple transcript mappings: only
4357 unique ET sequences out of 40027 were mapped to
multiple transcripts. In contrast, SAGEmap-full resulted
in a high rate (70%) of unique ET sequences mapped to
multiple Unigene clusters. TAGmapper was the most
successful at mapping ET sequences to single Unigene
clusters, with three unique ET sequences out of four
mapped by TAGmapper to a single Unigene cluster.
TAGmapper and SAGEmap-full resulted in the smallest
numbers of unmapped ET sequences, whereas
SAGETTARIUS produced the most. Indeed, half of the
ET sequences did not obtain any match to VT when using
SAGETTARIUS. It is noteworthy that 86% of the
GSM14740 unique ET that remained unmatched to any
VT when using SAGETTARIUS corresponded to single
copy ET sequences.
Comparison of ETto CRT mappingproduced by different
mapping resources
The 40027 unique ET sequences generated by the
GSM14740 (SAGE_Brain_ependymoma_B_R1023)
experiment were mapped by SAGETTARIUS, TAG-
mapper, SAGEmap-reliable and SAGEmap-full mapping
resources. In each tool output, we searched for ET
sequences that were mapped to CRT or cytoplasmic
ribosomal-speciﬁc Unigene clusters. In the SAGETTAR-
IUS database, curated specialized libraries of VT to
CRT associations were built from 30 poly-adenylated
CRT sequences and their annotated isoforms. Important
diﬀerences in ET to CRT or Unigene cluster associations
were observed between the four mapping tools. Of
the 40027 diﬀerent ET sequences in the GSM14740
SAGE experiment, SAGETTARIUS mapped 72 unique
ET sequences to CRT. These CRT are the products of
72 ribosomal protein coding genes. Both TAGmapper
and SAGEmap-reliable tools mapped more than 660 ET
sequences of the GSM14740 experiment to cytoplasmic
ribosome-speciﬁc Unigene clusters and SAGEmap-full
associated more than 2400 ET with these Unigene clusters.
Our curated library of VT to CRT associations shows that
the S21, L7A, L4 and L13 CRT cannot be detected by the
Nla3 SAGE protocol. In contrast, TAGmapper proposed
a mapping of ET sequences to these four cytoplasmic
ribosome protein coding genes. Interestingly, the SAGE-
map-reliable mapping resource did not map any ET
sequence to S21, whose transcript product (NM_001024)
lacks an Nla3 anchoring enzyme site. In addition,
no ET sequence was mapped by SAGEmap-reliable and
SAGEmap-full for the L4 protein coding gene, which is
consistent with the SAGETTARIUS result.
UniqueET sequencesmapped to multiple transcripts
dueto IREsubsequences
In a sample of 8 SAGE experiments with the number of
unique ET sequences ranging from 2147 (GSM23394)
to 80 125 (GSM14799), we measured the rate of unique
ET sequences which matched VT derived from IRE
subsequences integrated into transcripts. The unique ET
sequences of all eight SAGE experiments were mapped
to transcripts by means of the SAGETTARIUS tool. For
each experiment, we counted the number of unique ET
sequences matching IRE-derived VT. In these examined
SAGE experiments, the IRE-derived ET sequences/unique
ET sequence ratio varies from 3 10
 3 to 13 10
 3,
depending on the mRNA expressed in a cell type. This
number is however negligible, showing that the power
of the SAGE protocol is not signiﬁcantly weakened by the
IRE-derived tag problem.
DISCUSSION
SAGE and LongSAGE are elegant and powerful mole-
cular biology methods designed to measure genome-wide
gene expression proﬁles. They rely on cloning and
sequencing techniques carried out on a high-throughput
scale. SAGE and LongSAGE have been applied to
various organisms and cell types and have generated
millions of ET, containing gene expression level informa-
tion. However, once the ET of an experiment have been
sequenced and counted, a major problem must be
addressed, determining which genes are expressed using
nucleotide sequences as short as 10 or 17nt.
Bioinformatics has taken up this challenge and two
problems have been identiﬁed. First, ET sequences may
map to several genes, and second, ET sequences may not
map to any gene. The reasons why ET sequences map to
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Figure 4. Number of unmapped, multiply mapped and single-
mapped ET sequences from the GSM14740 SAGE experiment
(40027 unique ET sequences). ET mappings have been carried out by
SAGETTARIUS, TAGmapper, SAGEmap-reliable and SAGEmap-full
resources.
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discussed recently (22). Brieﬂy, ET to multiple gene
mapping may be due to the sequence match between ET
originating from diﬀerent genes, while unmapped ET may
result from new gene expression discovery. In both cases,
sequencing errors, VT databases and the mapping
procedures themselves can strongly inﬂuence the rate
of multiply versus unmapped ET. We have developed a
new program and VT database, SAGETTARIUS, both
speciﬁcally designed to address the problem of ET to
multiple gene mapping. When developing this resource,
we also wished to provide the biologist with a practical
means of planning ET sequencing stages during a
SAGE project.Among the current mapping tools,
SAGETTARIUS is the most successful in decreasing
the rate of ET mapping to multiple transcripts.
SAGETTARIUS progressively maps ET sequences to
libraries of VT to transcript associations, which are
hierarchized according to primary sequence reliability.
Thanks to this progressive and reductive mapping
procedure, SAGETTARIUS avoids ET to multiple
transcript mappings which are likely to result from
sequencing errors. The number of ET which map
to multiple transcripts due to non-random IRE subse-
quences seems to be negligible. Indeed, it concerns only
3 10
 3 to 13 10
 3 unique ET sequences in a complete
collection of SAGE tags. Moreover, the LongSAGE
protocol eﬃciently reduces tag to multiple transcript
associations.
SAGETTARIUS has been developed to reduce the
number of VT associated with multiple transcripts.
In order to reliably associate VT to transcripts, we
decided to consider only mRNA sequences displaying a
30 poly-adenylated boundary. Indeed, the absence of a 30
poly-adenylated boundary might indicate an incomplete
mRNA sequence. Consequently, the most 30 anchoring
enzyme site cannot be eﬃciently determined and no robust
VT to transcript association can be derived. In mammals,
cleavage of the mRNA on the 30 boundary and its subse-
quent poly-adenylation to the newly formed 30 end occurs
10–30nt downstream of a speciﬁc nucleotide hexamer,
generally the AAUAAA pattern (41,42). However, in a
recent study carried out on 13942 human and 11155
mouse genes, it appeared that only 53.2% of the
poly-adenylation signals correspond to the canonical
AAUAAA hexamer (43). Moreover, current methods for
poly-adenylation signal prediction achieve moderate sensi-
tivity and speciﬁcity (44). Therefore, we have chosen not
to use mRNA sequences lacking a 30 poly-adenylated
boundary to derive VT to transcript associations even
in the case where a poly-adenylation signal could be
predicted.
The construction of the SAGETTARIUS database
of VT to transcript associations revealed that 30 poly-
adenylated transcript records are unexpectedly scarce
in Genbank. Thousands of human veriﬁed cDNA are
available in Genbank but most of them lack the crucial
30 poly-adenylated boundary (80%). Multi-pass sequen-
cing of transcripts including the 30 poly-adenylated
boundary are required to enrich VT databases with
high-quality sequences that can be used to derive robust
tag to transcript associations. The relative paucity of
30 poly-adenylated transcripts in Genbank could be
one of the reasons why SAGETTARIUS fails to map
a signiﬁcant percentage of ET sequences (49% of
GSM14740 unique ET sequences). This is surprising
since the SAGETTARIUS database contains more VT
to transcript associations than the number of estimated
genes and transcripts coded by the human or mouse
genomes. The lack of 30 poly-adenylated transcripts in
nucleic acid databases may also have encouraged other
mapping resources to overexceed the sensu stricto SAGE
tag deﬁnition by integrating internal tags into VT
databases, i.e. VT that are extracted from 50 anchoring
enzyme sites on 30 poly-adenylated transcript or VT
originating from transcripts lacking a 30 poly-adenylated
boundary, thus generating new VT possibilities and
decreasing the rate of unmapped tags. Some of these
internal tags might be the result of alternative 30 poly-
adenylation or mRNA alternative splicing but in the
absence of any validation, these VT remain putative and
their associations should be considered with caution.
TAGmapper and SAGEmap resources map most ET
but the risk of generating multiple mapping increases
when the VT database includes internal tags. Another
possibility that might explain the high rate of unmapped
ET when using SAGETTARIUS could be that the
unmapped ET represent novel transcripts whose
sequences are not yet available in the nucleic acid
transcript databases. Using SAGETTARIUS to map the
40027 GSM14740 unique ET sequences to transcripts,
we observed that 86% of the unmapped ET are
single-copy sequences and thus probably correspond to
low-abundant transcripts. Indeed, three abundance classes
of mRNA have been previously deﬁned: high-, medium-
and low-abundance (32). The sequencing of EST
(the major source of database transcript records) seems
to have technically reached a plateau in new transcript
discovery (20). Thus, high- and medium-abundant
transcripts may have been identiﬁed and made available
in databases, but low-abundant transcripts are less
well characterized (7). In contrast, SAGE performs
signiﬁcantly better than the EST approach to detect
low-abundant transcripts. Consistent with our results, it
has been shown in Drosophila melanogaster that 55%
of the unique ET sequences generated by a SAGE
experiment could not be mapped to any known
Drosophila transcripts. Furthermore most of these ET
sequences displayed low-copy numbers (45). In addition,
in the mouse, 66% of unique ET sequences generated by
a LongSAGE experiment could not be mapped to any
known gene (14). Finally, it is unlikely that all unmapped
single-copy ET are the result of sequencing errors.
Since an ET sequence has a 10% chance of being false,
only 10% of all single copy ET are expected to be false
and thus unmapped.
The mapping of ET sequences to CRT implemented
in SAGETTARIUS allows us to propose four major ET
e122 Nucleic Acids Research, 2007, Vol. 35, No. 18 PAGE 10 OF12sequencing stages during a human or mouse SAGE
project. We found that 63 CRT-speciﬁc tags could be
detected with a probability greater than 0.66 with a ﬁrst
run of 10000 sequenced ET (stage 1). This ﬁrst sequencing
stage provides the best information beneﬁt to sequencing
eﬀort ratio for CRT detection whereas the subsequent
three stages require increased sequencing eﬀorts in order
to detect additional CRT. Due to the rapid increase of
CRT-speciﬁc tag detection during stage 1, we recommend
that biologists who are planning a SAGE project should
sequence at least 10000 ET. Moreover, 100000 sequenced
ET (stage 3) represents a major sequencing stage since it
allows the detection of almost all CRT. Sequencing more
than 100000 ET provides the lowest information beneﬁt
to sequencing eﬀort ratio for CRT detection. However,
it may be crucial to sequence more than 100000 ET in
order to detect other transcripts. Discrepancies in the
detection of expression have been observed between some
human and mouse CRT (SA, L37 and L26). These results
should thus be taken with caution. Indeed, we have
observed that RefSeq-RNA entries for these speciﬁc CRT
are derived from HTC sequences. Therefore, their VT
to transcript associations must be veriﬁed. We are aware
that our analysis does not provide an accurate quantita-
tive diﬀerential CRT expression study between the SAGE
experiments. However, in this study our aims basically
were (i) to present a tool to map human and mouse ET
(ii) to verify whether the available CRT sequence records
were of suﬃcient quality (30 sequence poly-adenylation,
veriﬁed cDNA sequences) to allow an accurate mapping
of the 80 human and 79 mouse CRT-speciﬁc tags and
(iii) to determine the minimal number of ET required to
detect all the CRT-speciﬁc tags for both organisms. For
human, the quality of SAGETTARIUS VT to CRT
associations is satisfying since 82% of the CRT records
are supported by veriﬁed cDNA and display a 30 poly-
adenylated boundary. For the mouse, the library is less
satisfying since only 20% of CRT are veriﬁed cDNA and
the remaining are derived from HTC sequences of more
variable quality. A comparative analysis of CRT expres-
sion levels between the diﬀerent SAGE experiments is now
conceivable for the human organism. In contrast, for the
mouse, the VT to CRT association quality must ﬁrst be
improved. Recently, using micro-array data, it has been
shown in 30 diﬀerent human cell types, that most CRT
are coordinately expressed with higher signals in some
speciﬁc tissues, and that 17 are expressed in a tissue-
speciﬁc manner (46). Our human VT to CRT association
library represents a valuable resource to cross-validate the
microarray CRT data with transcript expression infor-
mation from SAGE experiments.
In conclusion, SAGETTARIUS is a new high-through-
put ET to transcript mapper integrating its own database
of VT to transcript associations. It performs high quality
ET to transcript mapping for human and mouse organ-
isms, Nla3 and Sau3A anchoring enzymes and SAGE
and LongSAGE protocols. SAGETTARIUS has the
advantage of signiﬁcantly reducing the rate of multiply
mapped tags. However, because of the high rate of
unmapped ET, it is advisable to use SAGETTARIUS in
combination with other tools.
SUPPLEMENTARY DATA
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